What Happened
Kailyn Marie Smotherman, 35, of Sand Springs, Montana, was sentenced to three years of probation after pleading guilty to tampering with fentanyl and other controlled substances while serving as nursing director at Garfield County Health Center.
Staff discovered the tampering when they entered Smotherman's locked office to retrieve a narcotics log and found it in disarray, along with hospital stock narcotics, an IV pole, tourniquets, needles, replacement vial caps and labels, and suspected blood on surfaces. A subsequent search recovered numerous tampered or emptied fentanyl vials and other controlled substances, and an FDA forensic chemist confirmed the drugs had been tampered with and adulterated. Staff reported concern that patients may have received saline instead of pain medication in the months before the discovery.
Smotherman pleaded guilty in December 2025 to tampering with consumer products, and was sentenced on April 29, 2026, to three years of probation.
What Went Wrong
The health center's nursing director was able to accumulate tampering supplies and tampered vials over an extended period before discovery, with patients potentially receiving saline instead of pain medication in the interim. Key failures included:
- A senior clinical leader's locked office and narcotics-log access were not subject to routine oversight that could have surfaced irregularities sooner.
- Tampered and emptied vials accumulated in sufficient volume to be recovered in a single search, indicating no interim reconciliation caught the pattern.
- Concerns that patients received saline instead of pain medication went unraised until the tampering evidence was physically discovered.
- Detection depended on a chance discovery while retrieving a log, not on scheduled controlled-substance audits.
How It Could Have Been Prevented
- Apply controlled-substance oversight and audit requirements to leadership and clinical-director roles, not only front-line staff.
- Conduct frequent, unannounced reconciliation of narcotics logs against actual vial stock, especially in small rural facilities with limited pharmacy staffing.
- Investigate patient reports of inadequate pain relief as a possible diversion indicator rather than a clinical-only concern.
- Restrict and log access to narcotics logs and controlled-substance storage areas so irregularities are caught through routine review, not chance discovery.
Related Guidance
- Hospital Diversion Prevention Checklist — Hospital self-assessment, 8 sections 63 items, including audit and access controls applicable to leadership roles.
- 15 Red Flags of Drug Diversion — Behavioral and physical indicators including tampered vials and unexplained patient pain reports.
- DEA Form 106 Guide — Theft and significant-loss reporting obligations and timelines.